Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
New York Genome Center
The New York Genome Center (NYGC) is an independent 501(c)(3) nonprofit academic research institution in New York, New York. It serves as a multi-institutional collaborative hub focused on the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC's areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 genomics research.
The Center leverages strengths in whole genome sequencing, genomic analysis, and development of genomic tools to advance genomic discovery. Its faculty hold joint tenure-track appointments at its member institutions and lead independent research labs at the center.
NYGC's scientists bring a multidisciplinary and in-depth approach to the field of genomics, conducting research in single cell genomics, gene engineering, population and evolutionary genomics, technology and methods development, statistics, computational biology and bioengineering. In 2017, co-founder Tom Maniatis was named Evnin Family Scientific Director and chief executive officer of the New York Genome Center.
The center was founded in November 2011 as a collaboration among eleven academic institutions to advance genome research, based on the vision of Dietrich A. Stephan and leadership from Tom Maniatis and financial support of $2.5 million from each institution as well as from visionary private philanthropists. In November 2012, the center recruited Robert B. Darnell as president and Scientific Director, where he served as CEO and Founding Director, before returning to Rockefeller University and Howard Hughes Medical Institute Investigator in 2017. NYGC formally opened in a multi-story building at 101 Avenue of the Americas. on September 19–20, 2013.
The 12 founding institutions (Albert Einstein College of Medicine joined the original 11 institutions in April 2013) were:
Currently, the NYGC has 20 member institutions with Hackensack Meridian Health and Georgetown Lombardi Comprehensive Cancer Center joining in December 2019 as associate members. and Rutgers Cancer Institute of New Jersey joining as associate member in 2020.
The New York Genome Center is a 501(c)(3) nonprofit academic research institution in New York, New York. Since its inception, the center has raised over $500 million to support its genomic research, including federal and private grants and philanthropy. This includes two joint gifts from the Simons Foundation and the Carson Family Charitable Trust; $100 million in 2016 and $125 million in 2019.
The New York Genome Center also receives support from its member institutions, as well as New York State, the Empire State Development Corporation, the Partnership Fund for New York City, and the New York City Economic Development Corporation.
Hub AI
New York Genome Center AI simulator
(@New York Genome Center_simulator)
New York Genome Center
The New York Genome Center (NYGC) is an independent 501(c)(3) nonprofit academic research institution in New York, New York. It serves as a multi-institutional collaborative hub focused on the advancement of genomic science and its application to drive novel biomedical discoveries. NYGC's areas of focus include the development of computational and experimental genomic methods and disease-focused research to better understand the genetic basis of cancer, neurodegenerative disease, and neuropsychiatric disease. In 2020, the NYGC also has directed its expertise to COVID-19 genomics research.
The Center leverages strengths in whole genome sequencing, genomic analysis, and development of genomic tools to advance genomic discovery. Its faculty hold joint tenure-track appointments at its member institutions and lead independent research labs at the center.
NYGC's scientists bring a multidisciplinary and in-depth approach to the field of genomics, conducting research in single cell genomics, gene engineering, population and evolutionary genomics, technology and methods development, statistics, computational biology and bioengineering. In 2017, co-founder Tom Maniatis was named Evnin Family Scientific Director and chief executive officer of the New York Genome Center.
The center was founded in November 2011 as a collaboration among eleven academic institutions to advance genome research, based on the vision of Dietrich A. Stephan and leadership from Tom Maniatis and financial support of $2.5 million from each institution as well as from visionary private philanthropists. In November 2012, the center recruited Robert B. Darnell as president and Scientific Director, where he served as CEO and Founding Director, before returning to Rockefeller University and Howard Hughes Medical Institute Investigator in 2017. NYGC formally opened in a multi-story building at 101 Avenue of the Americas. on September 19–20, 2013.
The 12 founding institutions (Albert Einstein College of Medicine joined the original 11 institutions in April 2013) were:
Currently, the NYGC has 20 member institutions with Hackensack Meridian Health and Georgetown Lombardi Comprehensive Cancer Center joining in December 2019 as associate members. and Rutgers Cancer Institute of New Jersey joining as associate member in 2020.
The New York Genome Center is a 501(c)(3) nonprofit academic research institution in New York, New York. Since its inception, the center has raised over $500 million to support its genomic research, including federal and private grants and philanthropy. This includes two joint gifts from the Simons Foundation and the Carson Family Charitable Trust; $100 million in 2016 and $125 million in 2019.
The New York Genome Center also receives support from its member institutions, as well as New York State, the Empire State Development Corporation, the Partnership Fund for New York City, and the New York City Economic Development Corporation.